Skip to content

Pelthos Therapeutics Inc.

PTHS

CIK 0001919246

← back to feed
Revenue (TTM)
$16.8M
Q1 May 2026
Net Income (TTM)
−$31.89M
−444.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$16.98
−61.5% YoY Q1 May 2026
Gross Margin
76.3%
Q1 May 2026
Operating Margin
-199.6%
Q1 May 2026
Net Margin
-189.9%
Q1 May 2026
Free Cash Flow (TTM)
−$16.02M
Q1 May 2026
Cash
$31.98M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.48M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings